AAAAAA

   
Results: 1-18 |
Results: 18
CONTINUOUS-INFUSION, A MODERN, ALTERNATIVE FORM OF THERAPY ESPECIALLYFOR V.-WILLEBRAND-DISEASE TYPE-III
Authors: AUERSWALD G AUBERGER K KREUZ W
Citation: G. Auerswald et al., CONTINUOUS-INFUSION, A MODERN, ALTERNATIVE FORM OF THERAPY ESPECIALLYFOR V.-WILLEBRAND-DISEASE TYPE-III, Blood, 90(10), 1997, pp. 164-164
THE IMMUNE-RESPONSE TO FACTOR-VIII IN HEMOPHILIA-A PATIENTS IS MORE COMPLEX THAN SUGGESTED BY THE BETHESDA ASSAY
Authors: KLINGE J AUERSWALD G BUDDE U KLOSE H KREUZ W LENK H SCANDELLA D
Citation: J. Klinge et al., THE IMMUNE-RESPONSE TO FACTOR-VIII IN HEMOPHILIA-A PATIENTS IS MORE COMPLEX THAN SUGGESTED BY THE BETHESDA ASSAY, Blood, 90(10), 1997, pp. 2056-2056
VIGABATRIN AS INITIAL THERAPY FOR INFANTILE SPASMS - A EUROPEAN RETROSPECTIVE SURVEY
Authors: AICARDI J HAUSER E STEINBOCK H SZYPER M HOLSTEEN V OSTERGAARD J PEDERSEN SA TAUDORF K BARTHEZCARPENTIER MA BADINANDHUBERT N BERQUIN P BOULLOCHE J BOURGEOIS M CARRIERE JP CHABROL B CHIRON C CLARIS O ECHENNE B GAUTHIERMOREL D LIVET MO LOPEZ N MANCINI J NETTER JC QUILLEROU D RICHELME CH ROUSSELLE C DESTMARTIN A DESWARTE M AUERSWALD G BRANDL U KURLEMANN G SIEMES H SPOHR HL AARTS WFM BEGEER JH HEERSMA DJ LAAN LAEM PETERS ACB CAVAZZUTTI GB CURATOLO P FOIS A FRANZONI E GOBBI G INCORPORA G VIGEVANO F CAMPISTOL J CAMPOS J CASAS C HERRANZ JL NIETO M PRATS JM AMARK P BLENNOW G THEORELL K TONNBY B HAENGGELI CA WEISSERT M APPLETON UKR ROBINSON R DESOUSA C THOMAS N ANDERMANN F APPLETON R",ARZIMANOGLOU,"BOYD S BRANDT W BUTI D DULAC O FARRELL K MOSHE S MOTTE J PLOUIN P SHIELDS WD MUMFORD JP DUMAS C WOOD S
Citation: J. Aicardi et al., VIGABATRIN AS INITIAL THERAPY FOR INFANTILE SPASMS - A EUROPEAN RETROSPECTIVE SURVEY, Epilepsia, 37(7), 1996, pp. 638-642
INCIDENCE OF INHIBITORS IN PREVIOUSLY UNTREATED HEMOPHILIA PATIENTS -PRELIMINARY-RESULTS OF A PROSPECTIVE MULTICENTER STUDY OF THE PEDIATRIC WORKING GROUP TO THE GTH MAN-SOCIETY-OF-THROMBOSIS-AND-HEMOSTASIS-RESEARCH)
Authors: KLOSE HJ AUERSWALD G ESCURIOLAETTINGSHAUSEN C KREUZ W LENK H MARTINEZSAGUER I BUDDE U
Citation: Hj. Klose et al., INCIDENCE OF INHIBITORS IN PREVIOUSLY UNTREATED HEMOPHILIA PATIENTS -PRELIMINARY-RESULTS OF A PROSPECTIVE MULTICENTER STUDY OF THE PEDIATRIC WORKING GROUP TO THE GTH MAN-SOCIETY-OF-THROMBOSIS-AND-HEMOSTASIS-RESEARCH), Blood, 88(10), 1996, pp. 3031-3031
IMMUNE TOLERANCE THERAPY IN PEDIATRIC HEMOPHILIACS WITH FACTOR-VIII INHIBITORS - 14 YEARS FOLLOW-UP
Authors: KREUZ W EHRENFORTH S FUNK M AUERSWALD G MENTZER D JOSEPHSTEINER J BEEG T KLARMANN D SCHARRER I KORNHUBER B
Citation: W. Kreuz et al., IMMUNE TOLERANCE THERAPY IN PEDIATRIC HEMOPHILIACS WITH FACTOR-VIII INHIBITORS - 14 YEARS FOLLOW-UP, Haemophilia, 1(1), 1995, pp. 24-32
1ST REPORT OF A PROSPECTIVE MULTINATIONAL PHARMACOVIGILANCE STUDY FORHEMOPHILIA-A PATIENTS TREATED WITH A NEW DOUBLE INACTIVATED FACTOR-VIII CONCENTRATE, OCTAVI-SDPLUS
Authors: AUERSWALD G GOUDEAU A PRESTON FE ROSENDAAL FR VERMYLEN J
Citation: G. Auerswald et al., 1ST REPORT OF A PROSPECTIVE MULTINATIONAL PHARMACOVIGILANCE STUDY FORHEMOPHILIA-A PATIENTS TREATED WITH A NEW DOUBLE INACTIVATED FACTOR-VIII CONCENTRATE, OCTAVI-SDPLUS, Thrombosis and haemostasis, 73(6), 1995, pp. 1016-1016
CONTINUOUS-INFUSION OF FACTOR-VIII AFTER ELECTIVE SURGERY IN CHILDRENWITH HEMOPHILIA-A AND VON-WILLEBRAND DISEASE
Authors: AUERSWALD G KREUZ W AUBERGER K DEINHARDT M ROTH U
Citation: G. Auerswald et al., CONTINUOUS-INFUSION OF FACTOR-VIII AFTER ELECTIVE SURGERY IN CHILDRENWITH HEMOPHILIA-A AND VON-WILLEBRAND DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1024-1024
CLINICAL-STUDY OF THE BIOLOGICAL EFFICACY OF A HIGH-PURITY FVIII-C-VWF COMPLEX CONCENTRATE IN PATIENTS WITH VON-WILLEBRANDS-DISEASE
Authors: AUERSWALD G PONSEL G
Citation: G. Auerswald et G. Ponsel, CLINICAL-STUDY OF THE BIOLOGICAL EFFICACY OF A HIGH-PURITY FVIII-C-VWF COMPLEX CONCENTRATE IN PATIENTS WITH VON-WILLEBRANDS-DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1171-1171
LOW-RISK OF INTRAFAMILIAL HEPATITIS-C TRANSMISSION IN HEPATITIS-C POSITIVE CHILDREN WITH COAGULATION DISORDERS
Authors: KLARMANN D KREUZ W AUBERGER K AUERSWALD G STOHR S LENZ E RABENAU H GANDENBERGER S ROTH W GOETHE JW
Citation: D. Klarmann et al., LOW-RISK OF INTRAFAMILIAL HEPATITIS-C TRANSMISSION IN HEPATITIS-C POSITIVE CHILDREN WITH COAGULATION DISORDERS, Thrombosis and haemostasis, 73(6), 1995, pp. 1459-1459
HEPATITIS-C AND PASTEURIZED FACTOR-VIII AND FACTOR-IX CONCENTRATES
Authors: KREUZ W KLARMANN D AUBERGER K AUERSWALD G RABENAU H GURTLER L ROGGENDORF M
Citation: W. Kreuz et al., HEPATITIS-C AND PASTEURIZED FACTOR-VIII AND FACTOR-IX CONCENTRATES, Thrombosis and haemostasis, 73(6), 1995, pp. 1459-1459
HEPATITIS-C AND PASTEURIZED FACTOR-VIII AND FACTOR-IX CONCENTRATES
Authors: KLARMANN D KREUZ W AUERSWALD G AUBERGER K RABENAU H GURTLER L ROGGENDORF M
Citation: D. Klarmann et al., HEPATITIS-C AND PASTEURIZED FACTOR-VIII AND FACTOR-IX CONCENTRATES, Thrombosis and haemostasis, 73(4), 1995, pp. 736-737
PATIENT-TO-PATIENT TRANSMISSION OF HEPATITIS-C VIRUS
Authors: KLARMANN D KREUZ W AUBERGER K AUERSWALD G LENZ E ROTH W KORNHUBER B
Citation: D. Klarmann et al., PATIENT-TO-PATIENT TRANSMISSION OF HEPATITIS-C VIRUS, Lancet, 345(8962), 1995, pp. 1444-1445
FACTOR-VIII INHIBITORS IN PATIENTS WITH HEMOPHILIA-A - EPIDEMIOLOGY OF INHIBITOR DEVELOPMENT AND INDUCTION OF IMMUNE TOLERANCE FOR FACTOR-VIII
Authors: KREUZ W BECKER S LENZ E MARTINEZSAGUER I ESCURIOLAETTINGSHAUSEN C FUNK M EHRENFORTH S AUERSWALD G KORNHUBER B
Citation: W. Kreuz et al., FACTOR-VIII INHIBITORS IN PATIENTS WITH HEMOPHILIA-A - EPIDEMIOLOGY OF INHIBITOR DEVELOPMENT AND INDUCTION OF IMMUNE TOLERANCE FOR FACTOR-VIII, Seminars in thrombosis and hemostasis, 21(4), 1995, pp. 382-389
CONTINOUS INFUSION OF FACTOR-VII AFTER ELECTIVE SURGERY IN CHILDREN WITH HEMOPHILIA-A AND VON-WILLEBRAND DISEASE
Authors: AUERSWALD G AUBERGER K KREUZ W DEINHARD M ROTH U
Citation: G. Auerswald et al., CONTINOUS INFUSION OF FACTOR-VII AFTER ELECTIVE SURGERY IN CHILDREN WITH HEMOPHILIA-A AND VON-WILLEBRAND DISEASE, Blood, 86(10), 1995, pp. 3445-3445
A NEW-TYPE OF CONGENITAL DYSFIBRINOGEN, FIBRINOGEN BREMEN, WITH AN A-ALPHA GLY-17 TO VAL SUBSTITUTION ASSOCIATED WITH HEMORRHAGIC DIATHESISAND DELAYED WOUND-HEALING
Authors: WADA Y NIWA K MAEKAWA H ASAKURA S SUGO T NAKANISHI M AUERSWALD G POPP M MATSUDA M
Citation: Y. Wada et al., A NEW-TYPE OF CONGENITAL DYSFIBRINOGEN, FIBRINOGEN BREMEN, WITH AN A-ALPHA GLY-17 TO VAL SUBSTITUTION ASSOCIATED WITH HEMORRHAGIC DIATHESISAND DELAYED WOUND-HEALING, Thrombosis and haemostasis, 70(3), 1993, pp. 397-403
ABSENCE OF HEPATITIS-A AFTER TREATMENT WITH PASTEURIZED FACTOR-VIII CONCENTRATES IN CHILDREN WITH HEMOPHILIA-A AND VON-WILLEBRAND DISEASE
Authors: KREUZ W AUERSWALD G AUBERGER K KLARMANN D BECKER S BEEG T MENTZER D RABENAU H GURTLER L DOERR WD
Citation: W. Kreuz et al., ABSENCE OF HEPATITIS-A AFTER TREATMENT WITH PASTEURIZED FACTOR-VIII CONCENTRATES IN CHILDREN WITH HEMOPHILIA-A AND VON-WILLEBRAND DISEASE, Thrombosis and haemostasis, 69(6), 1993, pp. 1100-1100
FACTOR-VIII INHIBITORS IN HEMOPHILIA - RAPID AND SUCCESSFUL INDUCTIONOF IMMUNOTOLERANCE AFTER EARLY AND CONTINUOUS HIGH-DOSE FACTOR-VIII
Authors: KREUZ W EHRENFORTH S AUERSWALD G MENTZER D BEEG T KLARMANN D FUNK M BECKER S STEINER JJ SCHARRER I KORNHUBER B
Citation: W. Kreuz et al., FACTOR-VIII INHIBITORS IN HEMOPHILIA - RAPID AND SUCCESSFUL INDUCTIONOF IMMUNOTOLERANCE AFTER EARLY AND CONTINUOUS HIGH-DOSE FACTOR-VIII, Thrombosis and haemostasis, 69(6), 1993, pp. 1101-1101
FREQUENCY AND CLINICAL RELEVANCE OF PREOPERATIVE ABNORMAL HEMOSTASEOLOGICAL FINDINGS IN CHILDHOOD - A 3 YEAR CROSS-SECTIONAL STUDY
Authors: MENTZER D EHRENFORTH S AUERSWALD G BEEG T KLARMANN D BECKER S JOSEPHSTEINER J SCHARRER I KREUZ W
Citation: D. Mentzer et al., FREQUENCY AND CLINICAL RELEVANCE OF PREOPERATIVE ABNORMAL HEMOSTASEOLOGICAL FINDINGS IN CHILDHOOD - A 3 YEAR CROSS-SECTIONAL STUDY, Thrombosis and haemostasis, 69(6), 1993, pp. 1294-1294
Risultati: 1-18 |